Esperion Therapeutics
ESPR
#6120
Rank
C$1.26 B
Marketcap
C$5.32
Share price
-1.79%
Change (1 day)
-1.83%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2025 (TTM): -C$39.65 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are C$0.30 Billion. In 2024 the company made an earning of C$10.39 Million, an increase over its 2023 earnings that were of -C$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$39.65 Million-481.27%
2024 C$10.39 M-104.99%
2023 -C$0.21 Billion-15.03%
2022 -C$0.25 Billion-20.61%
2021 -C$0.31 Billion84.28%
2020 -C$0.17 Billion35.75%
2019 -C$0.13 Billion-55.71%
2018 -C$0.28 Billion19.57%
2017 -C$0.24 Billion125.39%
2016 -C$0.11 Billion51.43%
2015 -C$68.25 Million36.45%
2014 -C$50.02 Million43.55%
2013 -C$34.85 Million145.26%
2012 -C$14.21 Million
2002 -C$40.51 Million-7.81%
2001 -C$43.94 Million15.03%
2000 -C$38.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-C$0.72 Billion 1,790.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.94 B-2,575.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.41 B-43,290.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$7.12 B-18,849.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$6.9 M-118.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-C$95.01 Million 149.91%๐Ÿ‡บ๐Ÿ‡ธ USA